These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24765652)

  • 1. Direct and real-time quantification of tenofovir release from ph-sensitive microparticles into simulated biological fluids using (1)h nuclear magnetic resonance.
    Zhang C; Zhang T; Oyler NA; Youan BC
    J Pharm Sci; 2014 Apr; 103(4):1170-1177. PubMed ID: 24765652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-Time Analysis of Tenofovir Release Kinetics Using Quantitative Phosphorus (
    Agrahari V; Meng J; Purohit SS; Oyler NA; Youan BC
    J Pharm Sci; 2017 Oct; 106(10):3005-3015. PubMed ID: 28414145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive and rapid HPLC quantification of tenofovir from hyaluronic acid-based nanomedicine.
    Agrahari V; Youan BB
    AAPS PharmSciTech; 2012 Mar; 13(1):202-10. PubMed ID: 22215290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an LC-MS method for measuring TNF in human vaginal tissue.
    Choi SO; Rezk N; Kim JS; Kashuba AD
    J Chromatogr Sci; 2010 Mar; 48(3):219-23. PubMed ID: 20223089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preformulation and development of a once-daily sustained-release tenofovir vaginal tablet tablet containing a single excipient.
    Mcconville C; Friend DR; Clark MR; Malcolm K
    J Pharm Sci; 2013 Jun; 102(6):1859-1868. PubMed ID: 23568749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.
    Zhang T; Sturgis TF; Youan BB
    Eur J Pharm Biopharm; 2011 Nov; 79(3):526-36. PubMed ID: 21736940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of atazanavir and darunavir interactions with lipids for developing pH-responsive anti-HIV drug combination nanoparticles.
    Duan J; Freeling JP; Koehn J; Shu C; Ho RJ
    J Pharm Sci; 2014 Aug; 103(8):2520-9. PubMed ID: 24948204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue.
    Dobard C; Sharma S; Martin A; Pau CP; Holder A; Kuklenyik Z; Lipscomb J; Hanson DL; Smith J; Novembre FJ; García-Lerma JG; Heneine W
    J Virol; 2012 Jan; 86(2):718-25. PubMed ID: 22072766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximized mucoadhesion and skin permeation of anti-AIDS-loaded niosomal gels.
    Zidan AS; Habib MJ
    J Pharm Sci; 2014 Mar; 103(3):952-64. PubMed ID: 24464823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentrations of tenofovir and emtricitabine in saliva: implications for preexposure prophylaxis of oral HIV acquisition.
    de Lastours V; Fonsart J; Burlacu R; Gourmel B; Molina JM
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4905-7. PubMed ID: 21788466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.
    Johnson TJ; Clark MR; Albright TH; Nebeker JS; Tuitupou AL; Clark JT; Fabian J; McCabe RT; Chandra N; Doncel GF; Friend DR; Kiser PF
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6272-83. PubMed ID: 23006751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenofovir plasma concentrations in post-menopausal versus pre-menopausal HIV-infected women.
    Gervasoni C; Meraviglia P; Landonio S; Riva A; Galli M; Rizzardini G; Cattaneo D
    J Antimicrob Chemother; 2013 May; 68(5):1206-7. PubMed ID: 23299572
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir.
    Akil A; Devlin B; Cost M; Rohan LC
    Mol Pharm; 2014 May; 11(5):1533-41. PubMed ID: 24693866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and Real-Time Quantification Of Bortezomib Release From Alginate Microparticles Using Boron (
    Coulibaly FS; Alnafisah AS; Oyler NA; Youan BC
    Mol Pharm; 2019 Mar; 16(3):967-977. PubMed ID: 30525665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal Polyelectrolyte Layer-by-Layer Films Based on Chitosan Derivatives and Eudragit
    Cazorla-Luna R; Martín-Illana A; Notario-Pérez F; Bedoya LM; Tamayo A; Ruiz-Caro R; Rubio J; Veiga MD
    Mar Drugs; 2020 Jan; 18(1):. PubMed ID: 31936439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic activity of tenofovir and nevirapine combinations released from polycaprolactone matrices for potential enhanced prevention of HIV infection through the vaginal route.
    Dang NT; Sivakumaran H; Harrich D; Shaw PN; Davis-Poynter N; Coombes AG
    Eur J Pharm Biopharm; 2014 Oct; 88(2):406-14. PubMed ID: 24887313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial results finally show potential for microbicidal HIV gel.
    Mohammadi D
    Lancet Infect Dis; 2010 Sep; 10(9):587. PubMed ID: 20815108
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiviral activity of genital tract secretions after oral or topical tenofovir pre-exposure prophylaxis for HIV-1.
    Herold BC; Dezzutti CS; Richardson BA; Marrazzo J; Mesquita PM; Carpenter C; Huber A; Louissaint N; Marzinke MA; Hillier SL; Hendrix CW
    J Acquir Immune Defic Syndr; 2014 May; 66(1):65-73. PubMed ID: 24457633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure.
    Castillo-Mancilla JR; Zheng JH; Rower JE; Meditz A; Gardner EM; Predhomme J; Fernandez C; Langness J; Kiser JJ; Bushman LR; Anderson PL
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):384-90. PubMed ID: 22935078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single dose pharmacokinetics of oral tenofovir in plasma, peripheral blood mononuclear cells, colonic tissue, and vaginal tissue.
    Louissaint NA; Cao YJ; Skipper PL; Liberman RG; Tannenbaum SR; Nimmagadda S; Anderson JR; Everts S; Bakshi R; Fuchs EJ; Hendrix CW
    AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1443-50. PubMed ID: 23600365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.